An objective measure of response on whole-body MRI in metastatic hormone sensitive prostate cancer treated with androgen deprivation therapy, external beam radiotherapy, and radium-223.

Valentina GiacomettiArthur C GreyAaron J McCannKevin M PriseAlan R HounsellConor K McGarryPhilip G TurnerJoe M O'Sullivan

Published in: The British journal of radiology (2024)

Measurements of T1w WBMRI normalized intensity may allow identifying potentially useful response biomarkers correlating with survival, radiological response and biochemical progression.

Keyphrases

prostate cancer
squamous cell carcinoma
early stage
small cell lung cancer
stem cells
computed tomography
magnetic resonance
radiation induced
bone marrow
contrast enhanced
cell therapy